WAVE Life Sciences Ltd (WVE)-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:WAVE Life Sciences Ltd (WVE) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8013370
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月28日
◆ページ数:44
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
WAVE Life Sciences Ltd (WAVE), formerly WAVE Life Sciences Pte Ltd is a genetic medicine company that develops stereopure nucleic acid therapies. The company’s pipeline products comprise multiple oligonucleotide modalities including antisense, exon-skipping and single-stranded RNAi, among others. It utilizes its proprietary synthetic chemistry platform to design, develop and commercialize nucleic acid therapeutics. The company’s stereopure nucleic acid therapeutics are developed to affect the production of disease associated proteins and target rare genetic diseases. It controls the orientation of the chemical linkages. WAVE is headquartered in Cambridge, Massachusetts, the US.

WAVE Life Sciences Ltd (WVE) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
WAVE Life Sciences Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
WAVE Life Sciences Ltd, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
WAVE Life Sciences Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
WAVE Life Sciences Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
WAVE Life Sciences Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
WAVE Life Sciences Ltd, Pharmaceuticals & Healthcare, Deal Details 10
Venture Financing 10
WaVE Life Sciences Raises USD66 Million in Series B Financing Round 10
WaVe Life Sciences Raises USD18 Million in Series A Financing 12
Partnerships 13
ReadCoor and WAVE Life Sciences Enter into Research Agreement 13
nLife Therapeutics Enters into Research Agreement with WAVE Life Sciences 14
Wave Life Sciences Enters into Research Agreement with University of Dundee 15
Wave Life Sciences Enters into Licensing Agreement with Max Planck Innovation 16
Wave Life Sciences Enters into Research Agreement with Children’s Hospital of Philadelphia 18
Wave Life Sciences Enters into Research Agreement with University of Oxford 19
Licensing Agreements 20
Pfizer Enters into Licensing Agreement with WAVE Life Sciences 20
Equity Offering 21
WAVE Life Sciences Prices Public Offering of Shares for USD100 Million 21
Wave Life Sciences Completes IPO For USD111.9 Million 23
WAVE Life Sciences Ltd – Key Competitors 25
WAVE Life Sciences Ltd – Key Employees 26
WAVE Life Sciences Ltd – Locations And Subsidiaries 27
Head Office 27
Other Locations & Subsidiaries 27
Recent Developments 28
Financial Announcements 28
Aug 09, 2017: Wave Life Sciences Reports Second Quarter 2017 Financial Results and Provides Business Update 28
May 10, 2017: WAVE Life Sciences Reports First Quarter 2017 Financial Results and Provides Business Update 30
Mar 16, 2017: WAVE Life Sciences Reports Fourth Quarter and Full-Year 2016 Financial Results and Provides Business Update 32
Nov 09, 2016: WAVE Life Sciences Reports Third Quarter 2016 Financial Results and Provides Business Update 34
Aug 15, 2016: WAVE Life Sciences Reports Second Quarter 2016 Financial Results and Provides Business Update 36
May 16, 2016: WAVE Life Sciences Reports First Quarter 2016 Financial Results and Provides Business Update 38
Mar 30, 2016: WAVE Life Sciences Reports Fourth Quarter and Full Year 2015 Financial Results and Provides Business Update 39
Corporate Communications 40
Nov 10, 2016: WAVE Life Sciences Appoints Christian Henry to its Board of Directors 40
Aug 17, 2016: WAVE Life Sciences Appoints Keith Regnante as Chief Financial Officer 41
Product News 42
01/06/2017: WAVE Life Sciences Provides Update on Duchenne Muscular Dystrophy Program WVE-210201 42
Other Significant Developments 43
May 09, 2016: WAVE Life Sciences to Advance Next-Generation Nucleic Acid Therapies to Address Unmet Need in Duchenne Muscular Dystrophy 43
Appendix 44
Methodology 44
About GlobalData 44
Contact Us 44
Disclaimer 44

List of Tables
WAVE Life Sciences Ltd, Pharmaceuticals & Healthcare, Key Facts, 2016 2
WAVE Life Sciences Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
WAVE Life Sciences Ltd, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
WAVE Life Sciences Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
WAVE Life Sciences Ltd, Deals By Therapy Area, 2011 to YTD 2017 8
WAVE Life Sciences Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
WaVE Life Sciences Raises USD66 Million in Series B Financing Round 10
WaVe Life Sciences Raises USD18 Million in Series A Financing 12
ReadCoor and WAVE Life Sciences Enter into Research Agreement 13
nLife Therapeutics Enters into Research Agreement with WAVE Life Sciences 14
Wave Life Sciences Enters into Research Agreement with University of Dundee 15
Wave Life Sciences Enters into Licensing Agreement with Max Planck Innovation 16
Wave Life Sciences Enters into Research Agreement with Children’s Hospital of Philadelphia 18
Wave Life Sciences Enters into Research Agreement with University of Oxford 19
Pfizer Enters into Licensing Agreement with WAVE Life Sciences 20
WAVE Life Sciences Prices Public Offering of Shares for USD100 Million 21
Wave Life Sciences Completes IPO For USD111.9 Million 23
WAVE Life Sciences Ltd, Key Competitors 25
WAVE Life Sciences Ltd, Key Employees 26
WAVE Life Sciences Ltd, Subsidiaries 27

★海外企業調査レポート[WAVE Life Sciences Ltd (WVE)-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Scienion AG:医療機器:M&Aディール及び事業提携情報
    Summary Scienion AG (Scienion) is a life science company that offers solutions for liquid dispensing applications. The company’s products include scireader cl, innoscan microarray scanners, sciflexarrayer, sciliner lateral flow dispenser, sciconsumables- sciplexplates 96, scichip, scibuffer, scihybc …
  • Hess Corp (HES):電力:M&Aディール及び事業提携情報
    Summary Hess Corp (Hess) is a global independent energy company which carries out the exploration and production of crude oil and natural gas. It primarily operates in US, Denmark, the Joint Development Area of Malaysia/Thailand (JDA), and Malaysia. It offers fee-based services including gathering, …
  • Canadian Energy Services & Technology Corp (CEU):石油・ガス:M&Aディール及び事業提携情報
    Summary Canadian Energy Services & Technology Corp (CES) is a provider of chemical solutions. It provides technically advanced consumable chemical solutions for the North American oil and gas industry. The total solution provided by the company includes the drill-bit, at the point of completion and …
  • PharMerica Corporation:企業の戦略・SWOT・財務情報
    PharMerica Corporation - Strategy, SWOT and Corporate Finance Report Summary PharMerica Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Orsted AS (ORSTED):企業の財務・戦略的SWOT分析
    Orsted AS (ORSTED) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • Tufts Medical Center-医療機器分野:企業M&A・提携分析
    Summary Tufts Medical Center (TMC), formerly New England Medical Center Hospital Inc, a subsidiary of Tufts University School of Medicine, is an academic medical center that provides patient care services. The center offers treatments for brain tumor, breast cancer, cardiac arrhythmia, cardiomyopath …
  • Duke Energy Corporation:企業の戦略・SWOT・財務情報
    Duke Energy Corporation - Strategy, SWOT and Corporate Finance Report Summary Duke Energy Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • WKN AG:電力:M&Aディール及び事業提携情報
    Summary WKN AG (WKN), formerly WKN WindKraft Nord AG, a subsidiary of PNE Wind AG, is a renewable energy service provider that develops wind farms and various photovoltaic projects. The company offer services portfolio includes project planning, development, financing, realisation, and repowering. I …
  • Snyder’s-Lance Inc:企業の戦略的SWOT分析
    Snyder's-Lance Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and ser …
  • Voltalia SA (VLTSA):企業の財務・戦略的SWOT分析
    Voltalia SA (VLTSA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • eircom Limited (eir):戦略・SWOT・企業財務分析
    eircom Limited (eir) - Strategy, SWOT and Corporate Finance Report Summary eircom Limited (eir) - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Challenger Ltd.:企業の戦略・SWOT・財務情報
    Challenger Ltd. - Strategy, SWOT and Corporate Finance Report Summary Challenger Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Reliance Capital Ltd:企業のM&A・事業提携・投資動向
    Reliance Capital Ltd - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Reliance Capital Ltd Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A …
  • SonaCare Medical LLC:医療機器:M&Aディール及び事業提携情報
    Summary SonaCare Medical LLC (SonaCare Medical), formerly US HIFU LLC is a medical device company that manufactures ultrasound surgical ablation systems. The company's products comprise sonablate 450 and sonatherm. It develops technologies for urological indications providing procedures that control …
  • 4imprint Group plc (FOUR):企業の財務・戦略的SWOT分析
    4imprint Group plc (FOUR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Ferroglobe PLC (GSM):企業の財務・戦略的SWOT分析
    Ferroglobe PLC (GSM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Continental Engineering Corporation:企業の戦略・SWOT・財務情報
    Continental Engineering Corporation - Strategy, SWOT and Corporate Finance Report Summary Continental Engineering Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, …
  • Oracle Corporation (ORCL):企業の財務・戦略的SWOT分析
    Oracle Corporation (ORCL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Optus Inc:企業の戦略的SWOT分析
    Optus Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. Th …
  • Breg Inc-医療機器分野:企業M&A・提携分析
    Summary Breg Inc (Breg) is a medical device company that manufactures and distributes cold therapy products. The company offers products, which include cold therapy products, hip braces, elbow or wrist braces, knee braces, shoulder braces, spine braces, ankle braces, home therapy kits, and others. I …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆